Class assignment designed to engage students about grant proposals. This presentation, coupled with Grant Proposal Synopsis(other attached file), details a grant proposal I constructed that aids in the health of low-income children from the Appalachian region.
Class assignment designed to engage students about grant proposals. This presentation, coupled with Grant Proposal Presentation(other attached file), details a grant proposal I constructed that aids in the health of low-income children from the Appalachian region.
Pulp therapy for the baby bottle syndromeJake_Berry
Children’s oral health is as important as our own. They are susceptible to teeth decay the same way we are, and it is important to pay attention to their teeth as early as possible.
Class assignment designed to engage students about grant proposals. This presentation, coupled with Grant Proposal Synopsis(other attached file), details a grant proposal I constructed that aids in the health of low-income children from the Appalachian region.
Class assignment designed to engage students about grant proposals. This presentation, coupled with Grant Proposal Presentation(other attached file), details a grant proposal I constructed that aids in the health of low-income children from the Appalachian region.
Pulp therapy for the baby bottle syndromeJake_Berry
Children’s oral health is as important as our own. They are susceptible to teeth decay the same way we are, and it is important to pay attention to their teeth as early as possible.
Interested in global public health? Bridge to Health Medical and Dental has worked in partnership with local grassroots organizations and government agencies in rural communities across southwestern Uganda and Kenya to provide education and training, clinical services, and build innovative solutions to complex problems. Come learn about these initiatives, connect with Rotarians who build sustainable collaborations to improve health and education, and be inspired to take action.
Improving Access to Healthcare for Impoverished Communities Rotary International
Interested in global public health? Bridge to Health Medical and Dental has worked in partnership with local grassroots organizations in rural communities in southwestern Uganda and Ethiopia to provide education and training, clinical services, and build innovative solutions to complex problems. Come learn about these initiatives, connect with Rotarians who build sustainable collaborations to improve health and education, and be inspired to take action.
South Carolina Childhood Cancer Research Lab PresentationGoing Places, Inc
Childhood Cancer Research at the Medical University of South Carolina September 12, 2014 Jacqueline M Kraveka, D.O. Associate Professor Director, Pediatric Oncology Research Laboratory Department of Pediatrics Division of Hematology-Oncology
Successful and Effective Strategies and Resources for Health Education Proje...Rotary International
The Health Education and Wellness Rotarian Action
Group can assist clubs with organizing effective and
sustainable health fairs as well as provide resources for
creating or enhancing health education programs. You’ll
hear project updates from three continents, learn about
opportunities to participate, and have a chance to share
your own ideas for improving health education in your
community.
Moderator: Karl Diekman, District 5160 Rotary
Foundation Chair and Past District Governor, Rotary
Club of Woodland, California, USA
Dr Michael Sullivan
Associate Professor of Paediatric Oncology, University of Otago; Consultant Paediatric Haematologist/Oncologist in the Children’s Haematology Oncology Centre, Christchurch Hospital
Fran Lockie, a Paediatric Emergency and retrieval specialist, gives an update on paediatric resuscitation. This talk was given at the Bedside Critical Care Conference 2012 on Daydream Island.
12:30pm Murrumbidgee Room presentation on the work of the Icon group, Icon Cancer Foundation, and Epic Good Foundation, presented by Mark Middleton, Fiona Jonker, and Anita Heiss.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Treatment of Preventable Dental Cavities in Preschoolers
1. Treatment of Preventable
Dental Cavities in Preschoolers:
A Focus on Day Surgery under General
Anesthesia*
Saskatchewan Oral Health Coalition
October 26, 2015
*CIHI Report Released: October 17, 2013
2. In Canada during
2010-11 and 2011-12:
• 19,000 day surgery operations to treat dental
caries for children aged 1-5 (under 6).
• 31% of all day surgery is for dental treatment.
• Leading cause of day surgery for ages 1-5.
3. In Canada during
2010-11 and 2011-12:
• Represents 1 per 100 children for ages 1 to
younger than 5.
• 99% done under general anesthesia.
4. Day Surgery Rates
• 8.6 times higher among neighborhoods with higher
aboriginal populations, versus lower.
• 3.9 times higher for children from least affluent versus
most affluent neighborhoods.
• 3.1 times as high for children from rural versus urban
neighborhoods.
5. Day Surgery Rates
• 82 minutes was the average length of time children
were in the operating room.
• 79 minutes was the average length of time children
were in the operating room in Saskatchewan (3rd
lowest).
6. Public Cost
• $21.2 Million per year, for children age 1-5.
• Cost does not include caregiver costs, travel,
dental treatment, or anesthesiologists.
• Average cost per surgery ranged from $1,271 in
New Brunswick to $1,963 in Alberta.
• Saskatchewan was the 4th highest, with an
average cost of $1,699.
7. • In the four western provinces, the average
anesthesiologist cost per surgery ranged from
$240 in Manitoba to $361 in Saskatchewan.
• One in five families (or 22%) travelled 2 or more
hours for ECC day surgery visits.
• In Saskatchewan, 38% of children travelled 120
minutes one-way (4th highest in Canada).
Public Cost (continued)
8. • Day surgery rate is 35 per 1,000 children in
Saskatchewan (3rd highest rate in Canada).
• In Saskatchewan, SHR had the highest volume of
procedures.
• Volume by facility in Saskatchewan is 280 (7%)
private practice, versus 3,606 (93%) hospital.
Public Cost (continued)
